Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABUS | AZN | AMGN | GILD | VRTX |
| Company | Arbutus Biopharma Corp | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 4.51 | 91.18 | 321.82 | 121.07 | 442.55 |
| High | 4.63 | 91.45 | 323.00 | 122.25 | 448.28 |
| Low | 4.48 | 89.84 | 316.55 | 119.05 | 438.61 |
| Latest | 4.51 | 90.11 | 317.00 | 120.02 | 438.43 |
| Change | -0.01 | -1.17 | -4.23 | -1.17 | -3.61 |
| % Change | -0.22% | -1.28% | -1.32% | -0.97% | -0.82% |
| Volume | 348,256 | 3,534,912 | 1,379,159 | 2,200,672 | 564,002 |
| 20-Day Average Volume | 1,059,586 | 5,436,432 | 2,865,715 | 6,861,721 | 1,370,594 |
| Previous Close | 4.52 | 91.28 | 321.23 | 121.19 | 442.04 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 4.42 | 90.30 | 337.24 | 124.55 | 435.58 |
| 20-Day Raw Stochastic | 54.43% | 41.19% | 3.42% | 12.53% | 50.05% |
| 20-Day Relative Strength | 53.00 | 57.44 | 47.27 | 45.76 | 55.32 |
| Weighted Alpha | +38.00 | +38.24 | +17.46 | +26.94 | -1.95 |
| Today's Opinion | 72% Buy | 88% Buy | 80% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 72% Buy | 100% Buy | 80% Buy | 80% Buy | 24% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 88% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.15% since 12/02/25 | -0.16% since 12/02/25 | -6.14% since 12/02/25 | -3.28% since 12/02/25 | +1.70% since 12/02/25 |
| Low | 4.11 on 12/03/25 | 89.67 on 12/08/25 | 316.55 on 12/09/25 | 119.05 on 12/09/25 | 438.90 on 12/09/25 |
| High | 4.62 on 12/09/25 | 91.43 on 12/09/25 | 346.38 on 12/03/25 | 125.60 on 12/03/25 | 463.85 on 12/03/25 |
| 1-Month | |||||
| %Chg | +0.22% since 11/07/25 | +6.44% since 11/07/25 | -0.82% since 11/07/25 | +0.85% since 11/07/25 | +7.58% since 11/07/25 |
| Low | 4.08 on 11/20/25 | 85.85 on 11/10/25 | 316.55 on 12/09/25 | 117.13 on 11/10/25 | 410.50 on 11/10/25 |
| High | 4.87 on 11/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +4.16% since 09/09/25 | +10.84% since 09/09/25 | +13.43% since 09/09/25 | +3.53% since 09/09/25 | +11.11% since 09/09/25 |
| Low | 4.08 on 11/20/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 5.10 on 09/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +28.49% since 06/09/25 | +23.31% since 06/09/25 | +9.51% since 06/09/25 | +6.06% since 06/09/25 | -1.26% since 06/09/25 |
| Low | 3.04 on 06/30/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 5.10 on 09/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 869,305 | 283,098,176 | 172,976,256 | 150,358,016 | 112,153,952 |
| Shares Outstanding, K | 192,324 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 6,170,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -69,920,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 530,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -7,740,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.66 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.73 | 15.08 | 14.80 | 29.75 |